¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ : 2023-10-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ : 2023-10-21
±³À°ÀÏÀÚ : 2023-10-21
±³À°Àå¼Ò : ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë

±³À°ÁÖÁ¦ : 2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑ°³¿øÀÇÇùÀÇȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѳ»°úÀÇ»çȸ

´ã´çÀÚ : ±è¼º¸ñ
¿¬¶ôó : 051-321-2119

À̸ÞÀÏ : medmosquitoo@hanmail.net

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 500¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 30ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í »çÀüµî·Ï 4¸¸¿ø, ÇöÀåµî·Ï 5¸¸


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 15:00~15:30 SGLT-2 inhibitorÀÇ µîÀå°ú enavogliflozinÀÇ Ã¹°ÉÀ½ ±è¹Ì°æ ±³¼ö(ÇØ¿î´ë¹éº´¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 15:30~16:00 Achieving target blood pressure with Fimasartan combination therapy À̼±ÇÐ ±³¼ö(ºÎ»ê´ëÇб³º´¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 16:00~16:30 °³¿ø°¡¿¡¼­ Á¢ÇÏ´Â ¿Ü°úÁúȯÀÇ ÀÀ±Þ»óȲ(Ãæ¼ö¿°,°Ô½Ç¿°,Àåõ°ø,ÀåÆó»ö) ¹Úº´¼ö ±³¼ö(¾ç»êºÎ»ê´ëº´¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 16:30~17:00 ´ë°¡¿¡°Ô µè´Â ¿Ã¹Ù¸¥ »óºÎÀ§Àå°ü³»½Ã°æ °Ë»ç (»ðÀÔ,°üÂû,Æǵ¶¹ý) ÀÌÁØÇà ±³¼ö(¼­¿ï»ï¼ºº´¿ø)

ÈÞ½Ä 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 17:00~17:15 Coffee Break ()

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 17:15~18:15 À§¿°ÀÇ ºÐ·ù¿Í ºÎÀ§¿¡ µû¸¥ È£¹ß¾Ï ±è¼ºÀº ±³¼ö(°í½ÅÀÇ´ë)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 18:15~19:15 À§ ³»½Ã°æ ¼Ò°ß°ú Á¶Á÷°Ë»çÀÇ Â÷ÀÌ –¾ç¼º, ¾Ç¼º, Atypia, Atypical glands, Atypical cells ÀÌÁØÇà ±³¼ö(¼­¿ï»ï¼ºº´¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 19:15~19:45 Holistic treatment for achieving goals in patients with T2DM ¹ÚÁ¤Çö ±³¼ö(ºÎ»ê¹éº´¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 19:45~20:45 °£ÀåÁ¦ »ç¿ë¿øÄ¢°ú ó¹æ ÀßÇϱâ À̼º¿í ±³¼ö(À̼º¿í³»°úÀÇ¿ø)

±³À°½Ã°£ 10¿ù 21ÀÏ ºÎ»ê ·Ôµ¥È£ÅÚ 3Ãþ Å©¸®½ºÅ»º¼·ë 20:45~21:45 ÃֽŠ¼ÒÈ­±â ³»½Ã°æ º¸Çè û±¸ ±æ¶óÀâÀÌ ÃÖÀ±Á¾ ÀÌ»ç(´ëÇÑÀ§´ëÀå³»½Ã°æÇÐȸ)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³âµµ ´ëÇѳ»°úÀÇ»çȸ°³ÃÖ Ãß°èÇмú´ëȸ : 2023-10-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³â Á¦2Â÷ Á¦ÁÖ´ëÇб³º´¿ø Áö¿ªÀÇ»ç´ë»ó¿¬¼ö°­Á : 2023-10-21
´ÙÀ½±Û ´ëÇѽŰæ¿Ü°úÇÐȸ Á¦63Â÷ Ãß°èÇмú´ëȸ_3rd day : 2023-10-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
960 ÀüºÏ 2018³â ´ëÇÑ°ñ´ë»çÇÐȸ È£³²Áöȸ Á¦2Â÷ °ñ´Ù°øÁõ ¿¬¼ö°­Á : 2018-10-20 0 709 2018-09-19
959 ¼­¿ï ´ëÇѾȽŰæÀÇÇÐȸ 2018³â Ãß°èÇмú´ëȸ - Neurology of eye movements : 2018-10-20 0 940 2018-09-19
958 ¼­¿ï 22Â÷ ¼¼°è°¡Á¤ÀÇÇÐȸ ¼¼°èÇмú´ëȸ : 2018-10-19 0 727 2018-09-19
957 ¼­¿ï ´ëÇѺҾÈÀÇÇÐȸ PTSD¿¬±¸È¸ 15Áֳ⠱â³ä ½ÉÆ÷Áö¾ö : 2018-10-19 0 665 2018-09-19
956 ¼­¿ï °­³²¼¼ºê¶õ½ºº´¿ø ICT Fusion Biohealth Technology: Oppurtunity and Challenges : 2018-10-19 0 774 2018-09-19
955 ¼­¿ï Á¦25Â÷ ´ëÇѽŻý¾ÆÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-19 0 729 2018-09-19
954 ÀÎõ ´ëÇѽɺÎÀüÇÐȸ Á¦3ȸ °³¿øÀÇ ¿¬¼ö°­Á : 2018-10-19 0 530 2018-09-19
953 ¼­¿ï 2018 Çѱ¹Á¤½ÅºÐ¼®ÇÐȸ Ãß°èÇмú´ëȸ - '³ª'¿Í ÀÚ»ì : 2018-10-19 1 625 2018-09-19
952 ¼­¿ï 22Â÷ ¼¼°è°¡Á¤ÀÇÇÐȸ ¼¼°èÇмú´ëȸ : 2018-10-18 0 493 2018-09-19
951 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Á¦84ȸ ¼Ò¾Æû¼Ò³â°ú Àü°øÀÇ ¿¬¼ö°­Á : 2018-10-17 0 420 2018-09-19
950 ¼­¿ï Á¦44Â÷ ´ëÇÑÁ¤Çü¿Ü°ú¿¬±¸ÇÐȸ Ãß°èÇмú´ëȸ : 2018-10-17 0 524 2018-09-19
949 °æ±â ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾È°úÁúȯÀÇ ÃÖ½ÅÁö°ß : 2018-10-16 0 1,659 2018-09-19
948 °æ±â ¾ÆÁÖ´ëÇб³º´¿ø µ¿¹® Áö¿ªÀÇ»ç Áý´ãȸ : 2018-10-16 0 617 2018-09-19
947 ¼­¿ï ¼øõÇâÀÇ´ë ¼­¿ïº´¿ø Á¦263ȸ ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ ½ÉÆ÷Áö¾ö : 2018-10-15 0 1,159 2018-09-19
946 ¼­¿ï °¡Å縯´ëÇб³ ¼­¿ï¼º¸ðº´¿ø 2018³âµµ Á¦4ȸ ±âħ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2018-10-14 0 625 2018-09-19
1341 | 1342 | 1343 | 1344 | 1345 | 1346 | 1347 | 1348 | 1349 | 1350
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷